These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35743993)

  • 1. Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID.
    Tokumasu K; Ueda K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Nakano Y; Hasegawa T; Otsuka Y; Obika M; Hagiya H; Kataoka H; Otsuka F
    Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription of Kampo Formulations for Pre-natal and Post-partum Women in Japan: Data From an Administrative Health Database.
    Suzuki S; Obara T; Ishikawa T; Noda A; Matsuzaki F; Arita R; Ohsawa M; Mano N; Kikuchi A; Takayama S; Ishii T
    Front Nutr; 2021; 8():762895. PubMed ID: 34869533
    [No Abstract]   [Full Text] [Related]  

  • 3. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal trends in patients suffering from long COVID symptoms.
    Sunada N; Honda H; Nakano Y; Yamamoto K; Tokumasu K; Sakurada Y; Matsuda Y; Hasegawa T; Otsuka Y; Obika M; Hanayama Y; Hagiya H; Ueda K; Kataoka H; Otsuka F
    Endocr J; 2022 Oct; 69(10):1173-1181. PubMed ID: 35491089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Kampo Medicine in Modern Cancer Therapy: Towards Completion of Standard Treatment.
    Motoo Y
    J Nippon Med Sch; 2022 May; 89(2):139-144. PubMed ID: 34840211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kampo medicines for supportive care of patients with cancer: A brief review.
    Motoo Y; Cameron S
    Integr Med Res; 2022 Jun; 11(2):100839. PubMed ID: 35242536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-Onset Hypogonadism in a Male Patient with Long COVID Diagnosed by Exclusion of ME/CFS.
    Soejima Y; Otsuka Y; Tokumasu K; Nakano Y; Harada K; Nakamoto K; Sunada N; Sakurada Y; Hasegawa K; Hagiya H; Ueda K; Otsuka F
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional survey.
    Iwase S; Yamaguchi T; Miyaji T; Terawaki K; Inui A; Uezono Y
    BMC Complement Altern Med; 2012 Nov; 12():222. PubMed ID: 23167528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytotherapy for Cachexia: Where Do We Stand?
    Kuchta K; Cameron S
    Front Pharmacol; 2020; 11():917. PubMed ID: 32733236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of orthostatic dysregulation with Japanese (Kampo) herbal medicine ryokeijutsukanto.
    Sakata M; Egami H
    Explore (NY); 2021; 17(6):521-524. PubMed ID: 32335006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient Prescriptions of Kampo Formulations in Japan.
    Yamana H; Ono S; Michihata N; Jo T; Yasunaga H
    Intern Med; 2020 Nov; 59(22):2863-2869. PubMed ID: 32713918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
    Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
    Front Nutr; 2018; 5():126. PubMed ID: 30619872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Japanese Herbal Kampo Medicine in Patients With Acute Cardiovascular Disease　- A 12-Year Nationwide Cohort Analysis.
    Isogai T; Michihata N; Okada A; Morita K; Matsui H; Miyawaki A; Jo T; Yasunaga H
    Circ J; 2024 Apr; ():. PubMed ID: 38583961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and epidemiological features of healthcare workers after a coronavirus disease 2019 cluster infection in Japan and the effects of Kampo formulas-Hochuekkito and Kakkonto: A retrospective cohort study.
    Ogawa-Ochiai K; Ishikawa H; Nishimura H; Okajima M; Iinuma Y; Ito M
    Medicine (Baltimore); 2022 Jul; 101(28):e29748. PubMed ID: 35839019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of traditional herbal medicinal products in Japan.
    Maegawa H; Nakamura T; Saito K
    J Ethnopharmacol; 2014 Dec; 158 Pt B():511-5. PubMed ID: 25043783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.
    Chino A; Okamoto H; Hirasaki Y; Ueda K; Ogawa K; Namiki T
    J Altern Complement Med; 2011 Nov; 17(11):1075-7. PubMed ID: 22070441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Marketing Approval of Ethical Kampo Medicines].
    Hakamatsuka T
    Yakugaku Zasshi; 2017; 137(2):163-165. PubMed ID: 28154326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances.
    Terauchi M; Hiramitsu S; Akiyoshi M; Owa Y; Kato K; Obayashi S; Matsushima E; Kubota T
    Arch Gynecol Obstet; 2011 Oct; 284(4):913-21. PubMed ID: 21120510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological considerations of Kampo medicines in clinical use.
    Ikegami F; Fujii Y; Satoh T
    Toxicology; 2004 May; 198(1-3):221-8. PubMed ID: 15138045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.